Year archive

CLINUVEL PHARMACEUTICALS LIMITED — 2014 filings

All 59 regulatory filings released by CLINUVEL PHARMACEUTICALS LIMITED (CUV) in 2014, sourced directly from the official regulator.

59 Filings

2014 Period

2014 filings (59)

Filing	Released	Lang
Appendix 3B 13 pages 520.9KB Share Issue/Capital Change	2014-12-22	English
Change of Director's Interest Notice x 3 6 pages 636.6KB Director's Dealing	2014-12-22	English
European Commission approves SCENESSE 2 pages 279.0KB Regulatory Filings	2014-12-22	English
Long term use of SCENESSE in EPP published in BJD 2 pages 120.9KB Regulatory Filings	2014-12-14	English
Change in substantial holding 6 pages 285.6KB Regulatory Filings	2014-12-04	English
Investor Update Presentation 24 pages 1.2MB Regulatory Filings	2014-12-03	English
Appendix 3B 13 pages 524.8KB Capital/Financing Update	2014-12-03	English
Change of Director's Interest Notice * 4 8 pages 794.4KB Director's Dealing	2014-12-03	English
CEO's AGM presentation 42 pages 4.3MB Investor Presentation	2014-11-27	English
Chairman's Address 2 pages 91.2KB AGM Information	2014-11-27	English
Results of Meeting 4 pages 104.6KB Declaration of Voting Results & Voting Rights Announcements	2014-11-27	English
Letter to Shareholders 2 pages 261.2KB Management Reports	2014-11-04	English
Appendix 4C - quarterly 5 pages 136.2KB Interim / Quarterly Report	2014-10-28	English
Clinuvel to host investor teleconference 1 page 86. Regulatory Filings	2014-10-27	English
SCENESSE attains breakthrough European Market Authorisation 3 pages 132.0KB Capital/Financing Update	2014-10-26	English
Notice of Annual General Meeting/Proxy Form 30 pages 682.2KB AGM Information	2014-10-26	English
Annual Report to shareholders 74 pages 1.2MB Regulatory Filings	2014-10-26	English
Trading Halt 2 pages 248.4KB Regulatory Filings	2014-10-23	English
Lapse and Forfeit of Unlisted Conditional Performance Rights 1 Regulatory Filings	2014-10-09	English
AGM Date 1 page 219.0KB AGM Information	2014-10-09	English
SCENESSE data to be presented at EADV conference 1 Regulatory Filings	2014-10-07	English
EMA Oral Explanation Update 1 page 89.2KB Regulatory Filings	2014-09-25	English
Clinuvel invited to present at EMA's CHMP plenary session 1 Regulatory Filings	2014-09-21	English
JAMA Dermatology publishes SCENESSE vitiligo study results 2 pages 152.6KB Regulatory Filings	2014-09-18	English
Clinuvel enters a joint venture with Biotech Lab Singapore 2 pages 283.0KB Capital/Financing Update	2014-09-18	English
Response to ASX Price Query 5 pages 550.1KB Regulatory Filings	2014-09-15	English
Change in substantial holding 15 pages 905.9KB Regulatory Filings	2014-09-11	English
Change in substantial holding 14 pages 1.2MB Regulatory Filings	2014-09-10	English
Preliminary Final Report 61 pages 1.4MB Annual Report	2014-08-24	English
Chairman's Update 2 pages 297.0KB Management Reports	2014-08-17	English
Clinuvel declines unsolicited proposal from Retrophin 2 pages 118.7KB M&A Activity	2014-08-07	English
Appendix 3B 13 pages 526.2KB Share Issue/Capital Change	2014-08-06	English
Final Director's Interest Notice 2 pages 104.1KB Director's Dealing	2014-07-30	English
Appendix 4C - quarterly 5 pages 31.7KB Interim / Quarterly Report	2014-07-30	English
Becoming a substantial holder 6 pages 267.1KB Regulatory Filings	2014-07-29	English
Clinuvel receives an unsolicited bid for the Company 2 pages 93.1KB M&A Activity	2014-07-27	English
Mr Jack Wood 1 page 88.3KB Board/Management Information	2014-07-27	English
Proposal to acquire all the outstanding shares in Clinuvel P 5 pages 1.0MB M&A Activity	2014-07-27	English
Clinuvel Newsletter July 2014 2 pages 337.1KB Regulatory Filings	2014-07-15	English
US orphan-drug designation in Hailey-Hailey Disease 2 pages 316.6KB Regulatory Filings	2014-05-21	English
Appendix 3B 13 pages 527.5KB Share Issue/Capital Change	2014-05-19	English
Becoming a substantial holder 3 pages 55.5KB Regulatory Filings	2014-05-19	English
s.708A Notice 1 page 31.3KB Capital/Financing Update	2014-05-19	English
Management Update 3 pages 418.4KB Regulatory Filings	2014-05-18	English
Euro orphan designation in Hailey-Hailey Disease - SCENESSE 2 pages 122.7KB Regulatory Filings	2014-05-18	English
Clinuvel placement 2 pages 430.4KB Capital/Financing Update	2014-05-13	English
Trading Halt 1 page 77.9KB Regulatory Filings	2014-05-11	English
Trading Halt Request 1 page 158.7KB Capital/Financing Update	2014-05-11	English
Phase II vitiligo study commences in Singapore 3 pages 370.1KB Regulatory Filings	2014-05-05	English
Appendix 4C - quarterly 5 pages 136.6KB Interim / Quarterly Report	2014-04-16	English
Clinuvel Newsletter April 2014 2 pages 1.8MB Regulatory Filings	2014-04-13	English
Lapse and Forfeit of Unlisted Conditional Performance Rights 1 Regulatory Filings	2014-04-13	English
SCENESSE data to feature at American Academy of Dermatology 2 pages 129.8KB Regulatory Filings	2014-03-19	English
Half Yearly Report and Accounts 12 pages 317.3KB Interim / Quarterly Report	2014-02-25	English
Phase II study starts in skin disorder Hailey-Hailey Disease 4 pages 301.9KB Regulatory Filings	2014-02-09	English
Clinuvel Newsletter 3 pages 401.5KB Regulatory Filings	2014-02-03	English
Appendix 4C - quarterly 5 pages 136.6KB Interim / Quarterly Report	2014-01-30	English
EMA review of SCENESSE extended to mid-2014 2 pages 358.0KB Regulatory Filings	2014-01-29	English
Letter to Shareholders 2 pages 212.0KB Management Reports	2014-01-07	English

Filings by year

2026 21 filings
2025 67 filings
2024 96 filings
2023 62 filings
2022 63 filings
2021 59 filings
2020 69 filings
2019 72 filings
2018 54 filings
2017 32 filings
2016 52 filings
2015 36 filings
2014 59 filings
2013 39 filings
2012 38 filings
2011 47 filings
2010 56 filings
2009 45 filings
2008 43 filings
2007 54 filings
2006 10 filings
2005 74 filings
2004 49 filings
2003 53 filings
2002 2 filings